Exabis Library
Welcome to the e-CCO Library!
OP031: Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn’s disease: 12-month data from the PANTS study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP031: Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2 open-label 48-week extension study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP032: Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP032: Outcome of pregnancies in female IBD patients treated with vedolizumab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP033: Reduction of tissue pSTAT3 in Crohn's disease patients treated with filgotinib (GLPG0634, GS-6034), a JAK1-selective inhibitor
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP033: The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP034: Efficacy and safety of abrilumab in subjects with moderate to severe ulcerative colitis: results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP034: The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP035: Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for moderate to severe Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP035: NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP036: Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease: a nationwide cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP036: Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP037: Infants born to mothers with inflammatory bowel disease exhibit distinct microbiome features that persist up to 3 months of life
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP037: Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP038: Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP038: Impact of ileocecal resection in Crohn's disease patients on mucosal microbiota
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP03: Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP03: Highly stable epigenome-wide peripheral blood DNA methylation signatures accurately predict endoscopic response to adalimumab, vedolizumab and ustekinumab in Crohn's disease patients: The EPIC-CD study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP03: Inhibition of autophagy exacerbates intestinal fibrosis and EMT
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP03: Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: A randomized, placebo-controlled intervention study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM